ARCHIVES

DCE Board Approves Recompetition Of Two Major Contracts

This article is from The Cancer Letter archive.

Vol. 13 No. 42 | October 30, 1987

Download PDF Visit The Full Archive

Related Articles

IOM Recommends FDA Consolidate Each Drug’s Lifetime History

May 4, 2012

Somatuline Demonstrates 65.1 Percent Of Patients Progression-Free at 96 Weeks

July 25, 2014

Radiation Table Recommendations Completed

July 22, 1983

NCI RFA: Basic Biobehavioral Research

August 6, 1999

Commentary: NCI’s Budge Proposal ForFY2001 Offers A Blueprint for Research

November 26, 1999

DeVita Frustrated By Gap Between Bypass, “Real” Budgets, Seeks Better System To Develop Priorites

April 24, 1981